- Rosiglitazone - molecule of heaven or hell?2008 | Second Faculty of Medicine
- Rosiglitazone and treatment of hyperglycemia: facts and speculations2008 | Second Faculty of Medicine
- Rosiglitazone: Safe confirmation in 2008 year2008 | Second Faculty of Medicine
- Pharmacogenomics of metabolic effects of rosiglitazone2008 | First Faculty of Medicine
- Rosiglitazone in the prevention of diabetes and cardiovascular disease: Dream or reality?2008 | First Faculty of Medicine
- Rosiglitazone in the treatment of diabetes in 2010, what’s new?2010 | First Faculty of Medicine
- Prevention of diabetes with rosiglitazone: Evidence of benefit or unexpected harm?2008 | First Faculty of Medicine
- Rosiglitazone/metformin - fixed combination2006 | Second Faculty of Medicine
- ADOPT Study: clinical effect of rosiglitazone2007 | Second Faculty of Medicine
- Commentary on the article Rosiglitazone - a drug from the heavens or from hell?2008 | First Faculty of Medicine
- The first experience of czech diabetologists with therapy of rosiglitazon (Avandia)2002 | First Faculty of Medicine
- The effect of rosiglitazone on the expression of thrombogenic markers on leukocytes in type 2 diabetes mellitus2009 | First Faculty of Medicine, Faculty of Science
- Rosiglitazon and fenofibrate improve HDL metabolism assessed by FERhdlPublication without faculty affiliation
- The effect of rosiglitazone on homocysteine and creatinine levels in patients with type 2 diabetesPublication without faculty affiliation
- Rosiglitazone treatment of type 2 diabetes is associated with higher wall shear rate of the common carotid arteryPublication without faculty affiliation
- The effect of rosiglitazone is modulated by the genetic background in models of dyslipidemia and insulin resistance2004 | Faculty of Physical Education and Sport
- Fenofibrate and Rosiglitazone Improve Quality of Lipoproteins in Patients with Type 2 Diabetes Mellitus2008 | First Faculty of Medicine
- Pharmacoeconomics of the dosage of insulin vs rosiglitazone after failing of metformin in monotherapy in diabetes mellitus of tyspe 22007 | Second Faculty of Medicine
- Rosiglitazone little different: a view of the preventive cardiology2008 | First Faculty of Medicine
- Effect of rosiglitazone on microvascular reactivity in type 2 diabetic patientsPublication without faculty affiliation
- Rosiglitazone and fenofibrate improve HDL metabolism assessed by FERHDLPublication without faculty affiliation
- The effect of rosiglitazone is modulated by the genetic background in models of dyslipidemia and insulin resistance2004 | First Faculty of Medicine
- Effect of rosiglitazone on homocystein and creatinine levels in type 2 diabetic patientsPublication without faculty affiliation
- Pioglitazone in the treatment of type 2 diabetes mellitus in the year 2017: Current insight into benefits and disadvantages of this medication2017 | First Faculty of Medicine
- Effect of PPAR-gamma Agonist Rosiglitazone on Bone Mineral Density and Serum Adipokines in C57BL/6 Male Mice2011 | First Faculty of Medicine
- Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease2010 | Faculty of Medicine in Hradec Králové
- Rosiglitazone Influences the Expression of Leukocyte Adhesion Molecules and CD14 Receptor in Type 2 Diabetes Mellitus Patients2014 | First Faculty of Medicine
- Kontroverze kolem rosiglitazonuPublication without faculty affiliation
- Prominent role of liver in elevated plasma palmitoleate levels in response to rosiglitazone in mice fed high-fat diet2009 | First Faculty of Medicine
- Characterization of diet modulates pharmacogenetic interaction rosiglitazone action on metabolic and gene expression profiles in a model of metabolic syndromePublication without faculty affiliation